Back to mobile site
Get it on Google Play

Zealand Pharma gets EU recommendation for short bowel syndrome drug

September 18, 2026 6:11 AM EDT Send to a Friend
Zealand Pharma A/S (Nasdaq: ZEAL) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login